Cellebrite DI Ltd. (CLBT) Stock Forecast
CLBT analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.75 / 5 from 8 analysts
- Price target
- $15.36 average of analyst targets
- Upside to target
- +39.2% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $0.12
- 52-week range
- $10.44 – $19.28
CLBT analyst ratings
8 analystsNumber of analysts at each rating.
CLBT price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CLBT earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.16 | $0.14 | $0.17 | $0.14 | +12.9% | 8 |
| Current fiscal year (2026) | $0.55 | $0.42 | $0.59 | $0.51 | +7.6% | 8 |
| Next fiscal year (2027) | $0.65 | $0.54 | $0.73 | $0.55 | +19.1% | 8 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CLBT revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $145.9M | $144.1M | $148.0M | +15.8% | 8 |
| Current fiscal year (2026) | $556.7M | $555.0M | $560.4M | +17.0% | 8 |
| Next fiscal year (2027) | $640.9M | $626.3M | $650.0M | +15.1% | 8 |
CLBT EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CLBT revenue: reported and forecast
CLBT EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.16 | $0.16 | $0.16 | $0.16 | $0.16 | +0.4% | 5 up · 3 down |
| Current fiscal year (2026) | $0.55 | $0.55 | $0.55 | $0.55 | $0.55 | −1.1% | 3 up · 4 down |
| Next fiscal year (2027) | $0.66 | $0.64 | $0.65 | $0.65 | $0.65 | −1.2% | 3 up · 4 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CLBT earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CLBT beat in 11 of 12.
What analysts expect from CLBT
8 analysts cover Cellebrite DI; their consensus rating is strong buy (4.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $15.36, 39.2% above the latest close of $11.03. Analysts expect earnings of $0.55 per share for 2026, +7.6% from a year earlier. For 2027 the average estimate is $0.65 per share on revenue of $640.9 million. Cellebrite DI beat the EPS estimate in 11 of the last 12 quarters.
Related: CLBT income statement, CLBT key metrics, CLBT chart. See the CLBT stock overview for the latest quote and news.
CLBT forecast FAQ
What is Cellebrite DI's price target?
The average analyst price target for Cellebrite DI is $15.36, 39.2% above the latest close of $11.03.
Is Cellebrite DI a buy, hold or sell?
Of 8 analysts covering Cellebrite DI, 6 rate it a strong buy, 2 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Cellebrite DI's EPS forecast?
Analysts forecast $0.55 per share for 2026 (range $0.42 to $0.59); for 2027 the estimate is $0.65.
What is Cellebrite DI's revenue forecast?
The average revenue estimate for 2026 is $556.7 million, growth of 17.0%; for 2027 it is $640.9 million.
When does Cellebrite DI report earnings?
Cellebrite DI is expected to report results for the quarter ending September 30, 2026 on November 11, 2026 before the market opens; the EPS estimate is $0.12.
Does Cellebrite DI usually beat earnings estimates?
Cellebrite DI reported EPS at or above the analyst estimate in 11 of the last 12 quarters.